BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang Y, Jiang Z, Wang M, Ma L. Current understandings and clinical translation of nanomedicines for breast cancer therapy. Adv Drug Deliv Rev 2022;180:114034. [PMID: 34736986 DOI: 10.1016/j.addr.2021.114034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 das Neves J, Ensign L. Advances in drug delivery for women's health: A matter of gender equity. Adv Drug Deliv Rev 2022;182:114132. [PMID: 35090956 DOI: 10.1016/j.addr.2022.114132] [Reference Citation Analysis]
2 Wang Y, Huo J, Li S, Huang R, Fan D, Cheng H, Wan B, Du Y, He H, Zhang G. Self-Rectifiable and Hypoxia-Assisted Chemo-Photodynamic Nanoinhibitor for Synergistic Cancer Therapy. ACS Appl Mater Interfaces 2022;14:10092-101. [PMID: 35170301 DOI: 10.1021/acsami.1c23121] [Reference Citation Analysis]
3 Fraguas-sánchez AI, Lozza I, Torres-suárez AI. Actively Targeted Nanomedicines in Breast Cancer: From Pre-Clinal Investigation to Clinic. Cancers 2022;14:1198. [DOI: 10.3390/cancers14051198] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]